7th Congress of the South East Europe Neurosurgical Society (SeENS)

Türk Nöroşirürji Derneği


*The submission deadline for abstracts to be presented as part of the "Neurovascular Symposium" program has been extended to October 30, 2026.

*If you would like your abstract to be included in the “Neurovascular Symposium” program, please submit your abstract in Turkish by selecting the Neurovascular Surgery category. If you would like your abstract to be included in the “Seens Congress” program, you may submit your abstract in English by selecting your preferred category.

Points to Consider When Preparing an Abstract:

  • The abstract should consist of the following sections: Title, Objective, Methods, Results, and Conclusions, and each section must be entered into the corresponding field on the abstract submission page.
  • The title of the abstract must not exceed 200 characters (including spaces), and the abstract text must not exceed 3000 characters (including spaces). The title should accurately reflect the content of the study and be engaging to attract readers’ interest.
  • The Objective section should state the reason for conducting the study. The Methods section should clearly describe the number of cases/participants and the clinical, diagnostic, and experimental methods used. The Results section should present the quantitative and/or qualitative data obtained, including statistical results where applicable. In the Conclusions section, the outcomes derived from the data should be summarized, and the contribution of the study to scientific knowledge should be discussed.
  • The title and main text must not include any information that could identify the authors or their institutional affiliations.
  • If abbreviations are used in the abstract, they must be defined in full at their first occurrence.

Criteria Considered in the Peer Review Process.The following points are taken into consideration during peer review. Paying attention to these criteria when submitting abstracts will increase the likelihood of acceptance:

  • The study objective is valid, meaningful, and clearly stated,
  • The number of cases/participants is sufficient,
  • The methodology is clearly described and reproducible by other researchers,
  • For clinical studies, the study is prospective, includes a control group, and has an adequate follow-up period,
  • The results are clear and understandable,
  • Statistical analyses have been performed,
  • The data are interpreted correctly,
  • Appropriate and meaningful conclusions are drawn,
  • The study provides new knowledge or perspectives.
     

 

For technical support:
developer@iris-interaktif
03122360889